UTHR
United Therapeutics Corporation · Healthcare
EVP and General Counsel Paul A Mahon sold $1.4M of United Therapeutics Corporation
Sold$1,377,265
$229.54Price
6,000Shares
−14%Stake
What UTHR did after the filing
- The stock from Mon, Aug 21 open, $230.15
- −3.8%
- S&P 500, same days
- −3.3%
Measured over 30 trading days, to the Oct 3 close.
Traded Thu, Aug 17. Filed Fri, Aug 18, 4:30 PM ET, after the close. Returns use the Aug 21 open and the Oct 3 close. Not investment advice.